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shock in TNF dependent manner. (P1222)
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We report the generation of dual-specificity phosphatase 3 (DUSP3) deficient mice.
These mice develop normally and do not exhibit any spontaneous phenotype. However,
VHR-/- females, but not males, are resistant to LPS- and to polymicrobial infection-
induced septic shock. After LPS injection, while VHR-/- males and VHR+/+ mice of both
genders, displayed an increased serum levels of TNF-! and IFN , the levels of these
cytokines remained significantly low in the VHR-/- females. In vitro experiments using
peritoneal macrophages showed the same results suggesting that the systemic cytokines
profiles observed are macrophages-dependent. Adoptive transfer of VHR-/- females bone
marrow to irradiated VHR+/+ female mice, but not to VHR-/- or VHR+/+ males, protected
them from death after administration of LPS. Interestingly, VHR-/- females were sensitive
to TNF-!- induced lethality. We also report that the decrease of TNF-! production
observed in VHR-/- female’s macrophages after LPS activation was associated with a
decreased ERK1/2, but not MEK1/2, activation. Interestingly, pervanadate (PTP pan
inhibitor) treatment prior to LPS activation restored ERK1/2 activation in the VHR-deficient
macrophages, suggesting that VHR is targeting one of the ERK1/2 PTPs or DUSPs.
These results, together with our observation that DUSP3 is the most highly expressed
phosphatase in macrophages, suggest a key non-redundant role of VHR as positive
regulator of TNF-! in innate immune response in females.
